| Literature DB >> 29907492 |
Soichiro Nakahara1, Sarah Medland2, Jessica A Turner3, Vince D Calhoun4, Kelvin O Lim5, Bryon A Mueller6, Juan R Bustillo5, Daniel S O'Leary7, Jatin G Vaidya7, Sarah McEwen8, James Voyvodic9, Aysenil Belger10, Daniel H Mathalon11, Judith M Ford11, Guia Guffanti12, Fabio Macciardi13, Steven G Potkin13, Theo G M van Erp14.
Abstract
This study assessed genetic contributions to six cognitive domains, identified by the MATRICS Cognitive Consensus Battery as relevant for schizophrenia, cognition-enhancing, clinical trials. Psychiatric Genomics Consortium Schizophrenia polygenic risk scores showed significant negative correlations with each cognitive domain. Genome-wide association analyses identified loci associated with attention/vigilance (rs830786 within HNF4G), verbal memory (rs67017972 near NDUFS4), and reasoning/problem solving (rs76872642 within HDAC9). Gene set analysis identified unique and shared genes across cognitive domains. These findings suggest involvement of common and unique mechanisms across cognitive domains and may contribute to the discovery of new therapeutic targets to treat cognitive deficits in schizophrenia.Entities:
Keywords: GWAS; MCCB; Neuropsychology; PRS; Schizophrenia
Mesh:
Year: 2018 PMID: 29907492 PMCID: PMC6252137 DOI: 10.1016/j.schres.2018.05.041
Source DB: PubMed Journal: Schizophr Res ISSN: 0920-9964 Impact factor: 4.939